Actn2em1Kage
Endonuclease-mediated Allele Detail
|
Symbol: |
Actn2em1Kage |
Name: |
actinin alpha 2; endonuclease-mediated mutation 1, Katja Gehmlich |
MGI ID: |
MGI:7482516 |
Synonyms: |
Actn2 p.Met228Thr |
Gene: |
Actn2 Location: Chr13:12284312-12355613 bp, - strand Genetic Position: Chr13, 4.54 cM
|
Alliance: |
Actn2em1Kage page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:334092
|
Parent Cell Line: |
JM8.F6 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
|
Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
Mutation: |
|
Nucleotide substitutions
|
|
|
Mutation details: CRISPR/Cas9 technology generated a methionine to threonine substitution at amino acid 228 (p.M228T). Three silent base pair changes were also introduced to create an Hgal restriction site
for genotyping. p.M228T is a missense variant identified in the actin-binding domain in patients with hypertrophic cardiomyopathy.
(J:334092)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Actn2 Mutation: |
58 strains or lines available
|
|
Original: |
J:334092 Broadway-Stringer S, et al., Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2. Cells. 2023 Feb 24;12(5) |
All: |
1 reference(s) |
|